Literature DB >> 497086

Dosage and the pharmacokinetics of cytotoxic drugs.

J R Trounce.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 497086      PMCID: PMC1429797          DOI: 10.1111/j.1365-2125.1979.tb01003.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  18 in total

1.  Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system.

Authors:  L B Mellett
Journal:  Cancer Treat Rep       Date:  1977-07

2.  Drug interactions with antineoplastic agents.

Authors:  R D Warren; R A Bender
Journal:  Cancer Treat Rep       Date:  1977-10

3.  Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue.

Authors:  W H Isacoff; P F Morrison; J Aroesty; K L Willis; J B Block; T L Lincoln
Journal:  Cancer Treat Rep       Date:  1977-12

4.  Clinical pharmacology of anticancer drugs.

Authors:  B A Chabner; C E Myers; V T Oliverio
Journal:  Semin Oncol       Date:  1977-06       Impact factor: 4.929

5.  Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Authors:  R L Dedrick; C E Myers; P M Bungay; V T DeVita
Journal:  Cancer Treat Rep       Date:  1978-01

6.  Comparison of cell proliferation kinetics in human and experimental tumors: response to irradiation.

Authors:  M Tubiana; E Malaise
Journal:  Cancer Treat Rep       Date:  1976-12

Review 7.  Pharmacokinetics: selectivity of action related to physicochemical properties and kinetic patterns of anticancer drugs.

Authors:  C A Nichol
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

8.  Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics.

Authors:  A W Bleyer
Journal:  Cancer Treat Rep       Date:  1977-11

9.  Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection.

Authors:  W A Bleyer; R L Dedrick
Journal:  Cancer Treat Rep       Date:  1977-07

10.  Systemic methotrexate toxicity. A pharmacological study of its occurrence after intrathecal administration in a patient with renal failure.

Authors:  E C Cadman; W B Lundberg; J R Bertino
Journal:  Arch Intern Med       Date:  1976-11
View more
  4 in total

Review 1.  Recent progress and clinical importance on pharmacogenetics in cancer therapy.

Authors:  Thomas I Peng Soh; Wei Peng Yong; Federico Innocenti
Journal:  Clin Chem Lab Med       Date:  2011-09-28       Impact factor: 3.694

2.  Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice.

Authors:  M N Azmin; J F Stuart; K C Calman; A T Florence
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.

Authors:  A A Quyyumi; C Wright; L Mockus; M Shackell; G C Sutton; K M Fox
Journal:  Br Heart J       Date:  1985-01

4.  Bioorthogonal prodrug activation driven by a strain-promoted 1,3-dipolar cycloaddition.

Authors:  Siddharth S Matikonda; Douglas L Orsi; Verena Staudacher; Imogen A Jenkins; Franziska Fiedler; Jiayi Chen; Allan B Gamble
Journal:  Chem Sci       Date:  2014-11-14       Impact factor: 9.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.